Genes and pathways downstream of telomerase in melanoma metastasis
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Recent studies have demonstrated a role for telomerase in driving tumor progression, but its mechanism of action remains unclear. Here we show that stable, ribozyme-mediated suppression of mouse telomerase RNA reduced telomerase RNA expression, telomerase activity, and telomere length, which significantly reduced tumor invasion and metastatic potential. Our studies reveal that previously unidentified effects of telomerase may mediate its tumor-promoting effects. First, reducing telomerase activity induced a more dendritic morphology, accompanied by increased melanin content and increased expression of tyrosinase, a key enzyme in melanin biosynthesis. Second, gene expression profiling revealed that telomerase targeting down-regulated expression of several glycolytic pathway genes, with a corresponding decrease in glucose consumption and lactate production. Thus, telomerase activity controls the glycolytic pathway, potentially altering the energy state of tumor cells and thereby modulating tyrosinase activity and melanin production. These studies have important implications for understanding the mechanisms by which telomerase promotes tumor invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, an inverse correlation with the length of telomeres was shown for the development of cardiovascular disease [44-47], renal failure [48, 49], various cancers [50, 51], Alzheimer's disease [52], and Parkinson's disease [53].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [51]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citationAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Telomere states and cell fates
Blackburn, E. H. (2000) · Nature · doi:10.1038/35040500 · Cited by 1,377
Self-citationGreider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Self-citationInhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Telomeres: Beginning to Understand the End
Zakian, V. A. (1995) · Science · doi:10.1126/science.270.5242.1601 · Cited by 852
Kang, S. S., Kwon, T., Kwon, D. Y., & Do, S. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13085 · Cited by 480
Research works printed but not linked: 3
- A. Ludwig, G. Saretzki, P. S. Holm, F. Tiemann, M. Lorenz, T. Emrich Cancer Res. 61, 3053–3061 (2001).
- S. S. Kang, T. Kwon, D. Y. Kwon, S. I. Do J. Biol. Chem. 274, 3085–3090 (1999).
- W. Zhang, M. A. Piatyszek, T. Kobayashi, E. Estey, M. Andreeff, A. B. Deisseroth, W. E. Wright, J. W. Shay Clin. Cancer Res. 2, 799–803 (1996).
Cited by
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Ahmed, S., Passos, J. F., Birket, M. J., Beckmann, T., Brings, S., Peters, H., Birch-Machin, M. A., von Zglinicki, T., & Saretzki, G. (2008) · Journal of Cell Science · doi:10.1242/jcs.019372 · Cited by 491
“A better understanding of the mechanisms involved is of obvious importance, as telomerase is active in the vast majority of human cancers (Shay and Bacchetti, 1997) and might significantly contribute to tumorigenic potential (Bagheri et al., 2006; Stewart et al., 2002) and to the low sensitivity of many cancer cells t…”
BackgroundInfluentialMarkers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466
“Additionally, an inverse correlation with the length of telomeres was shown for the development of cardiovascular disease [44-47], renal failure [48, 49], various cancers [50, 51], Alzheimer's disease [52], and Parkinson's disease [53].”
BackgroundDNA damage in telomeres and mitochondria during cellular senescence: is there a connection?
Passos, J. F., Saretzki, G., & von Zglinicki, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm893 · Cited by 344
“(106) found that telomerase modulated glucose consumption and appeared to control the glycolytic pathway in tumour cells, thereby potentially altering the energy state.”
BackgroundTelomerase: central regulator of all of the hallmarks of cancer
Low, K. C., & Tergaonkar, V. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.07.001 · Cited by 257
Actions of human telomerase beyond telomeres
Cong, Y., & Shay, J. W. (2008) · Cell Research · doi:10.1038/cr.2008.74 · Cited by 229
Causes of genome instability: the effect of low dose chemical exposures in modern society
Langie, S. A. S., Koppen, G., Desaulniers, D., Al-Mulla, F., Al-Temaimi, R., Amedei, A., Azqueta, A., Bisson, W. H., Brown, D., Brunborg, G., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv031 · Cited by 209
TERT promoter mutations in telomere biology
Heidenreich, B., & Kumar, R. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.11.002 · Cited by 197
Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis
Singhapol, C., Pal, D., Czapiewski, R., Porika, M., Nelson, G., & Saretzki, G. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052989 · Cited by 196
“In recent years, however, evidence has accumulated that telomerase, and in particular its catalytic subunit TERT, is involved in various non-telomere-related functions such as regulation of gene expression, growth factors and cell proliferation [1–6].”
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
Heidenreich, B., Nagore, E., Rachakonda, P. S., Garcia-Casado, Z., Requena, C., Traves, V., Becker, J., Soufir, N., Hemminki, K., & Kumar, R. (2014) · Nature Communications · doi:10.1038/ncomms4401 · Cited by 189
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Saretzki, G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630095606 · Cited by 156
“In a follow-up study, the group addressed the question of how down regulation of telomerase can drive the differentiation of mouse melanoma cells in vitro, and influence metabolic regulation within these cells [84].”
BackgroundTelomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
Koh, C. M., Khattar, E., Leow, S. C., Liu, C. Y., Muller, J., Ang, W. X., Li, Y., Franzoso, G., Li, S., Guccione, E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79134 · Cited by 162
Self-citationA global pathway crosstalk network
Li, Y., Agarwal, P., & Rajagopalan, D. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn200 · Cited by 162
Robey, R. B., Weisz, J., Kuemmerle, N. B., Salzberg, A. C., Berg, A. S., Brown, D. G., Maurer, L. L., Palorini, R., Al‐Mulla, F., Al-Temaimi, R. A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv037 · Cited by 162
“In addition to its roles in maintaining chromosomal length, telomerase expression has been associated with increased Glc utilization, lactate accumulation and glycolytic enzyme expression (135).”
BackgroundTargeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway
Kelland, L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0422 · Cited by 141
Telomerase, mitochondria and oxidative stress
Saretzki, G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.05.004 · Cited by 128
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Vinagre, J., Pinto, V. S., Celestino, R., Reis, M., Pópulo, H., Boaventura, P., Melo, M., Catarino, T. A., Lima, J. P., Lopes, J. M., et al. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1608-4 · Cited by 142
“The suppression of telomerase activity in melanoma cell lines induced cellular differentiation and reduced the metastatic ability [6, 30].”
TERT promoter mutations in melanoma survival
Nagore, E., Heidenreich, B., Rachakonda, S., Garcia‐Casado, Z., Requena, C., Soriano, V., Frank, C., Traves, V., Quecedo, E., Sanjuan‐Gimenez, J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30042 · Cited by 119
Khan, I. M., Bishop, J., Gilbert, S. J., & Archer, C. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.08.002 · Cited by 116
TERT promoter mutations and long-term survival in patients with thyroid cancer
Kim, T. H., Kim, Y.-E., Ahn, S., Kim, J., Ki, C., Oh, Y. L., Kim, K., Yun, J. W., Park, W., Choe, J., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0219 · Cited by 112
“This relationship is consistent with in vitro evidence showing that the suppression of telomerase activity in melanoma cell lines induced cellular differentiation and reduced metastasis (Bagheri et al. 2006) or, vice-versa, the induction of differentiation”
ResultCellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
“Loss of p53 abrogated the response to short telomeres in mouse hepatocellular carcinomas [120].”
BackgroundRachakatla, R. S., Balivada, S., Seo, G., Myers, C. B., Wang, H., Samarakoon, T., Dani, R. K., Pyle, M. M., Kroh, F. O., Walker, B., et al. (2010) · ACS Nano · doi:10.1021/nn100870z · Cited by 93
“Many proteins have been found to be instrumental in the progression of melanoma.(17) 19 Two-”
Brennan, S. K., Wang, Q., Tressler, R., Harley, C. B., Go, N. F., Bassett, E., Huff, C. A., Jones, R. J., & Matsui, W. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012487 · Cited by 92
“In a similar fashion, short-term telomerase inhibition has been found to induce the differentiation of medulloblastoma and melanoma cells as well as sensitize glioblastoma CSC to cytotoxic chemotherapy [33,54–56].”
BackgroundDNA microarray analyses of melanoma gene expression: a decade in the mines
Hoek, K. S. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00412.x · Cited by 100
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
hTERT promotes cell adhesion and migration independent of telomerase activity
Liu, H., Liu, Q., Ge, Y., Zhao, Q., Zheng, X., & Zhao, Y. B. (2016) · Scientific Reports · doi:10.1038/srep22886 · Cited by 76
Boscolo‐Rizzo, P., Mosto, M. C. D., Rampazzo, E., Giunco, S., Mistro, A. D., Menegaldo, A., Baboçi, L., Mantovani, M., Tirelli, G., & Rossi, A. D. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9633-1 · Cited by 68
“zyme inhibiting telomerase activity significantly reduces metastatic progression in tumor-bearing mice [180, 181].”
BackgroundThe non-canonical functions of telomerase: to turn off or not to turn off
Romaniuk-Drapała, A., Paszel-Jaworska, A., Totoń, E., Lisiak, N., Hołysz, H., Królak, A., Grodecka-Gazdecka, S., & Rubiś, B. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4496-x · Cited by 71
Telomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 71
Telomerase reverse transcriptase in the regulation of gene expression
Zhou, J., Ding, D., Wang, M., & Cong, Y. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.1.284 · Cited by 63
“expression of glycolytic enzymes indicated a functional link between telomerase and cancer metabolism (56).”
BackgroundZhou, L., Zheng, D., Wang, M., & Cong, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.116 · Cited by 62
“Several recent studies however suggest that telomerase possess extracurricular activities involved in DNA repair [7], apoptosis [8], glycolysis [9], and tumorigenesis [3–6].”
BackgroundPeng, M., Wang, Y., Fu, Q., Sun, F., Na, N., & Ouyang, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00734 · Cited by 62
Correlation between telomerase and mTOR pathway in cancer stem cells
Doğan, F., & Avcı, Ç. B. (2017) · Gene · doi:10.1016/j.gene.2017.09.072 · Cited by 64
Molecular regulation of telomerase activity in aging
Nicholls, C., Li, H., Wang, J.-Q., & Liu, J.-P. (2011) · Protein & Cell · doi:10.1007/s13238-011-1093-3 · Cited by 53
“Intriguingly, inhibition of telomerase by ribozymes targeting hTERC down-regulates several key glycolytic genes and alters cellular morphology (Bagheri et al., 2006).”
TERT promoter mutations in clear cell renal cell carcinoma
Hosen, M. I., Rachakonda, P. S., Heidenreich, B., Sitaram, R. T., Ljungberg, B., Roos, G., Hemminki, K., & Kumar, R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29279 · Cited by 59
Mahfouz, N., Tahtouh, R., Alaaeddine, N., Hajj, J. E., Sarkis, R., Hachem, R. Y., RAAD, I. I., & Hilal, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179202 · Cited by 57
Lincz, L. F., Mudge, L.-M., Scorgie, F. E., Sakoff, J. A., Hamilton, C. S., & Seldon, M. (2008) · Neoplasia · doi:10.1593/neo.08644 · Cited by 63
“Furthermore, therapeutic induction of differentiation in some cancer cells is accompanied by a reduction in telomerase activity [48–51], and recent gene expression profiling has revealed that this is more likely to be a causative rather than consequential factor of cell maturation [52].”
BackgroundChapman, E., Kelly, G. P., & Knowles, M. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2168 · Cited by 60
“Although not a widely acknowledged function of telomerase, other studies have shown a reciprocal relationship between telomerase activity and differentiation (7, 8, 50-52).”
BackgroundTERT promoter mutations associate with fast‐growing melanoma
Nagore, E., Heidenreich, B., Requena, C., García‐Casado, Z., Martorell, A., Pont‐Sanjuan, V., Jiménez‐Sánchez, A. I., & Kumar, R. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12441 · Cited by 58
“Conversely, suppression of telomerase activity resulted in significant reduction in tumor and metastatic potential in a melanoma mouse model (Bagheri et al., 2006).”
BackgroundExploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Reyes-Uribe, P. I., Adrianzen-Ruesta, M. P., Deng, Z., Echevarría-Vargas, I. M., Mender, I., Saheb, S., Liu, Q., Altieri, D. C., Murphy, M. E., Shay, J. W., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0247-7 · Cited by 53
“In addition to its canonical role in maintaining telomere length, TERT has been recognized to regulate extra-telomeric processes [18–22].”
TERT Promoter Mutations and Telomerase in Melanoma
Guo, Y., Chen, Y., Zhang, L., Ma, L., Jiang, K., Yao, G., & Zhu, L. (2022) · Journal of Oncology · doi:10.1155/2022/6300329 · Cited by 57
“In a model of melanomamouse, inhibition of telomerase activity can significantly reduce the tumor’s potential for invasion and metastatic [18].”
BackgroundNew techniques in dermatopathology that help to diagnose and prognosticate melanoma
Carlson, J. A., Ross, J. S., & Slominski, A. T. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.007 · Cited by 55
Non-telomeric activities of telomerase
Majerská, J., Sýkorová, E., & Fajkus, J. (2011) · Molecular BioSystems · doi:10.1039/c0mb00268b · Cited by 48
PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma
Chen, Y.-J., Campbell, H. G., Wiles, A. K., Eccles, M. R., Reddel, R. R., Braithwaite, A. W., & Royds, J. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0058 · Cited by 52
Yang, F., Xian, R. R., Li, Y., Polony, T. S., & BEEMON, K. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709173104 · Cited by 47
Mennuni, C., Ugel, S., Mori, F., Cipriani, B., Iezzi, M., Pannellini, T., Lazzaro, D., Ciliberto, G., Monica, N. L., Zanovello, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1603 · Cited by 46
“tion of telomerase is commonly occurring in mouse tumors as well and abrogation of telomerase activity in mouse cancerous cells impairs their metastatic potential (11, 12).”
BackgroundTelomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target
Sagris, Μ., Theofilis, P., Antonopoulos, A. S., Tsioufis, K. P., & Tousoulis, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416010 · Cited by 49
Viswanath, P., Batsios, G., Ayyappan, V., Taglang, C., Gillespie, A. M., Larson, P. E. Z., Luchman, H. A., Costello, J., Pieper, R. O., & Ronen, S. M. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab093 · Cited by 45
The Role of Telomerase in Breast Cancer’s Response to Therapy
Judasz, E., Lisiak, N., Kopczyński, P., Taube, M., & Rubiś, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112844 · Cited by 47
“Some of them were involved in the glycolytic pathway, indicating a possible relationship between hTERC and cancer metabolism [42].”
BackgroundMa, J., Xu, R.-J., Ju, X., Wang, W.-H., Luo, Z., Liu, C., Yang, L., Li, B., Chen, J., Meng, B., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0419-19.2019 · Cited by 45
“In addition to its well known function to maintain telomere length during cell division, TERT has been shown to be involved in many other biological functions independent of its telomere regulatory function, such as the regulation of cell metabolism, growth factor secretion, mitochondria function, energy balance, and…”
BackgroundBrood size, telomere length, and parent-offspring color signaling in barn swallows
Costanzo, A., Parolini, M., Bazzi, G., Khoriauli, L., Santagostino, M., Possenti, C. D., Romanò, A., Nergadze, S. G., Rubolini, D., Giulotto, E., et al. (2016) · Behavioral Ecology · doi:10.1093/beheco/arw147 · Cited by 49
“However, an interplay between melanogenesis and telomere dynamics might be suggested by the observation that telomerase activity can affect early melanin biosynthetic pathways (Bagheri et al., 2006).”
BackgroundGenetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck
Liu, Z., Li, G., Wei, S., Niu, J., Wang, L., Sturgis, E. M., & Wei, Q. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq179 · Cited by 42
Uziel, O., Beery, E., Dronichev, V., Samocha, K., Gryaznov, S. M., Weiss, L., Slavin, S., Kushnir, M., Nordenberg, Y., Rabinowitz, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009132 · Cited by 44
“In addition to chemosensitization, telomere shortening affected another feature of the cancer cell; its migratory potential. The migration assay is considered to reflect the metastatic potential of the cell. These results are in accordance with the report showing that telomere shortening resulting from rybozyme mediat…”
ResultVidal-Cardenas, S. L., & Greider, C. W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp855 · Cited by 41
hTERT promotes the invasion of telomerase-negative tumor cells in vitro
Yang, Y. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000344 · Cited by 45
“Bagheri et al showed that telomerase activity controls the glycolytic pathway in melanoma, potentially altering the energy state of tumor cells, thereby promoting the invasion and metastasis of tumors (28).”
BackgroundIntegrated Nanosensors to Determine Levels and Functional Activity of Human Telomerase
Pérez, J. M. S., Grimm, J., Josephson, L., & Weissleder, R. (2008) · Neoplasia · doi:10.1593/neo.08350 · Cited by 41
“High levels of hTERTmRNA have been observed in most tumors with high telomerase activity [26], suggesting that hTERT is by itself an up-regulating factor in its own activation, essential in oncogenesis, tumor progression, and tumor invasion [27].”
BackgroundLing, X., Wen, L., & Zhou, Y. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4648 · Cited by 39
Kim, Y., Kim, K. T., Lee, S.-J., Hong, S., Moon, J.-Y., Yoon, E. K., Kim, S., Kim, E. O., Kang, S. H., Kim, S. K., et al. (2016) · Theranostics · doi:10.7150/thno.13621 · Cited by 38
“been reported to decrease glycolytic pathway genes in human melanoma cells and these genes possibly regulated by PI3K/Akt pathway [29,30].”
BackgroundQu, Y., Duan, Z., Zhao, F., Wei, D., Zhang, J., Tang, B., Li, J., Yang, C., & Mu, D. (2011) · Stroke · doi:10.1161/strokeaha.111.626325 · Cited by 36
RetractedTelomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
Kumar, N., & Sethi, G. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216459 · Cited by 41
Belgiovine, C., Chiodi, I., & Mondello, C. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167811 · Cited by 42
“Bagheri et al. (2006) found that telomerase RNA knockdown in a model of murine melanoma metastasis reduced telomere length, tumor invasion and metastatic potential.”
Parolini, M., Romanò, A., Costanzo, A., Khoriauli, L., Santagostino, M., Nergadze, S. G., Canova, L., Rubolini, D., Giulotto, E., & Saino, N. (2017) · Molecular Ecology · doi:10.1111/mec.14340 · Cited by 39
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease
Ait‐Aissa, K., Ebben, J. D., Kadlec, A. O., & Beyer, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.003 · Cited by 36
“Telomerase was also recently found to regulate metabolism and glycolysis in melanoma cells, directly impacting their ability to metastasize (30).”
BackgroundIndran, I. R., Hande, M. P., & Pervaiz, S. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.001 · Cited by 36
Kar, A., Saha, D., Purohit, G., Singh, A., Kumar, P., Yadav, V. K., Kumar, P., Thakur, R. K., & Chowdhury, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1109 · Cited by 33
“Indeed suppression of telomerase activity in tumour-bearing mice was found to significantly reduce metastatic progression (12,14).”
BackgroundInfluentialHow does the body know how old it is? Introducing the epigenetic clock hypothesis
Mitteldorf, J. J. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913090113 · Cited by 31
Yin, J., Li, Y., Yin, M., Sun, J., Liu, L., Qin, Q., Li, X., Long, L., Nie, S., & Wei, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050650 · Cited by 32
“TERT protein shows a high-level of expression in many tumors and it possibly contributes to unlimited cell division and carcinogenesis [64,65].”
BackgroundTelomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Shou, S., Maolan, A., Zhang, D., Jiang, X., Liu, F., Li, Y., Zhang, X., Geer, E., Pu, Z., Hua, B., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00597-9 · Cited by 31
“…which in turn promotes cancer cell proliferation, as well as its influence on downstream pathways that induce glycolysis, thereby facilitating cancer cell survival, metastasis, and invasion, are all intrinsically linked to TERT’s capacity for translocating in and out of the nucleus [187–189].”
Teralı, K., & Yılmazer, A. (2015) · Biochimie · doi:10.1016/j.biochi.2015.12.001 · Cited by 31
Role of Telomeres Shortening in Atherogenesis: An Overview
Yegorov, Y. E., Poznyak, A. V., Nikiforov, N. G., Starodubova, A. V., & Orekhov, A. N. (2021) · Cells · doi:10.3390/cells10020395 · Cited by 28
“Telomerase has been shown to affect the activity of glycolytic genes [19] and independently of telomerase activity, it stimulates transcription of genes associated with the epithelial-mesenchymal transition (vimentin and snail1) [20].”
BackgroundHigh TERT promoter mutation frequency in non‐acral cutaneous metastatic melanoma
Ekedahl, H., Lauss, M., Olsson, H. L., Griewank, K., Schadendorf, D., Ingvar, C., & Jonsson, G. G. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12500 · Cited by 30
“Potentially, in addition to its effect on telomere length and proliferation rate, telomerase might augment metastatic potential via other mechanisms, supporting earlier findings by Bagheri et al. (Bagheri et al., 2006).”
ResultMany Functions of Telomerase Components: Certainties, Doubts, and Inconsistencies
Udroiu, I., Marinaccio, J., & Sgura, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315189 · Cited by 26
“This enzyme is mainly used in glycolysis (Figure 7), a pathway (as described above) that seems to be upregulated by TERC [144].”
BackgroundBettegowda, C., Yip, S. S. F., Jiang, B., Wang, W., Clarke, M. J., Lazáry, Á., Gambarotti, M., Zhang, M., Sciubba, D. M., Wolinsky, J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz066 · Cited by 24
Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics
Smith‐Sonneborn, J. (2019) · Current Aging Science · doi:10.2174/1874609812666190620124324 · Cited by 25
Zou, M., Lv, G., Li, J., She, X., & Jiang, Y. (2016) · PubMed · Cited by 24
Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese
Dong, J., Cheng, Y., Zhu, M., Wen, Y., Wang, C., Wang, Y., Geng, L., Shen, W., Liu, J., Li, Z., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30702 · Cited by 25
“In addition, telomeres may drive tumor progression and metastasis by activating the glycolytic pathways.(33) The most commonly reported variant in the TERT gene, rs2736100, was first identified in lung cancer GWAS in European,(3) and consistently replicated in other European populations, Asians and African-Americans.”
BackgroundChen, P., Peng, J., Huang, L., Li, W., WANG, W.-Z., CUI, Z.-Q.-Q., Han, H., Gong, L., XIANG, D.-P., Qiao, S., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2563 · Cited by 22
Zhang, Y., Zhao, M., Li, S., Ren, Y., Su, L., Li, X., Yin, Z., & Zhou, B. (2014) · Medical Oncology · doi:10.1007/s12032-014-0018-4 · Cited by 22
Self-citationGenetic Variations in TERT-CLPTM1L Genes and Risk of Lung Cancer in a Chinese Population
Zhao, M., Zhang, Y., Shen, L., Ren, Y., Li, X., Yin, Z., & Zhou, B. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2809 · Cited by 22
“TERT, which regulates activity of telomerase and synthesis of telomere, shows a high-level of expression in many cancers, including lung cancer (Bagheri et al., 2006).”
BackgroundElectromagnetic Fields and Stem Cell Fate: When Physics Meets Biology
Tamrin, S. H., Majedi, F. S., Tondar, M., Sanati‐Nezhad, A., & Hasani‐Sadrabadi, M. M. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2016_4 · Cited by 22
Modulation of telomerase expression and function by miRNAs: Anti-cancer potential
Salamati, A., Majidinia, M., Asemi, Z., Sadeghpour, A., Oskoii, M. A., Shanebandi, D., Alemi, F., Mohammadi, E., Karimian, A., Targhazeh, N., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118387 · Cited by 23
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma
Minami, N., Hong, D., Stevers, N. O., Barger, C. J., Radoul, M., Hong, C., Chen, L., Kim, Y., Batsios, G., Gillespie, A. M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac112 · Cited by 22
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis
Lü, M., Deng, J., Cao, Y., Fang, D.-C., Zhang, Y., & Yang, S. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.471 · Cited by 20
“High TA may activate the glycolytic pathway to promote tumor growth and metastasis (43).”
Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration
Bezrookove, V., de Semir, D., Nosrati, M., Tong, S., Wu, C., Thummala, S., Dar, A. A., Leong, S. P. L., Cleaver, J. E., Sagebiel, R. W., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.369 · Cited by 20
Self-citationEnhanced migration and CXCR4 over-expression in fibroblasts with telomerase reconstitution
Qu, Y., Mao, M., Li, X., Zhang, L., Huang, X., Yang, C., Zhao, F., Xiong, Y., & Mu, D. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9740-6 · Cited by 20
“ing, and nuclear transport are abundant [12].”
Quantitative Analysis of the Effective Functional Structure in Yeast Glycolysis
la Fuente, I. M. D., & Cortés, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030162 · Cited by 19
“, glycolysis has a long history in cancer cell biology [5] and cell proliferation [6], there is a correlation between brain aerobic glycolysis and Amyloid-b plaque deposition which might precede the clinical manifestations of the Alzheimer disease [7], the”
BackgroundOjeda, D. S., López‐Costa, J. J., Sede, M. M., López, E. M., Berría, M. I., & Quarleri, J. F. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23294 · Cited by 19
TERT rs2736098 Polymorphism and Cancer Risk: Results of a Meta-analysis
Qi, H., Zou, P., Zhao, L., Zhu, J., & Gu, A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.7.3483 · Cited by 19
“In addition, telomerase may play a role in tumor progression and metastasis by activation of the glycolytic pathway and in suppression of tumor cell differentiation (Nosrati et al., 2004; Bagheri et al., 2006; Liu et al., 2010).”
BackgroundTelomere length, telomerase activity, stress, and aging
Im, S., Mikhelson, V. M., & Spivak, D. L. (2016) · Advances in Gerontology · doi:10.1134/s2079057016010136 · Cited by 19
Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics
Melicher, D., Buzás, E. I., & Falus, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1991-2 · Cited by 19
Kapitanov, G. (2012) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20127107 · Cited by 16
“The result does assume advantages for the cancer stem cell (higher proliferation rate, higher self-renewal probability), consistent with the characteristics associated with this type of cells [9][28] [16][17][12][37][5][25].”
Qin, Y., Guo, H. Y., Tang, B., & Yang, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2470 · Cited by 15
The crosstalk between glucose metabolism and telomerase regulation in cancer
Huang, M., Liu, M., Wang, R., Man, Y., Zhou, H., Xu, Z., & Wang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116643 · Cited by 14
Global expression profile of telomerase-associated genes in HeLa cells
Varshney, A., Ramakrishnan, S. K., Sharma, A., Santosh, B., Bala, J., Yadava, P. K., & Jaiswal, R. K. (2014) · Gene · doi:10.1016/j.gene.2014.06.018 · Cited by 12
“…2009), inhibitor of hTERT (Damm et al., 2001; Kraemer et al., 2006; Xiao et al., 2005), Tet-regulated expression of TERT in mice (Choi et al., 2008), retrovirus-mediated overexpression of hTERT (Choi et al., 2001), siRNA against hTR (Li et al., 2005) and ribozyme against hTR (Bagheri et al., 2006).”
BackgroundMarie-Egyptienne, D. T., Brault, M. E., Zhu, S., & Autexier, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.10.020 · Cited by 11
Inhibition of telomerase activity by NME2: impact on metastasis suppression?
Kar, A., & Chowdhury, S. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1077-y · Cited by 9
“Direct correlation between telomerase activity, hTERT levels and cellular invasion was found when ribozymemediated suppression of telomerase RNA (TER) levels in melanoma cells resulted in reduced telomerase activity and decreased invasive potential of melanoma cells (Bagheri et al., 2006).”
BackgroundRamakrishnan, S. K., Varshney, A., Sharma, A., Das, B. C., & Yadava, P. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-1729-z · Cited by 8
“Therefore, constituents of telomerase have been projected to have additional role besides telomere maintenance by having direct or indirect cross-talks with other cellular gene products [4, 5, 7, 11, 13].”
BackgroundRibozyme-Mediated Targeting of IκBγ Inhibits Melanoma Invasion and Metastasis
Torabian, S. Z., de Semir, D., Nosrati, M., Bagheri, S., Dar, A. A., Fong, S., Liu, Y., Federman, S. M., Simko, J. P., Haqq, C., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080207 · Cited by 9
Self-citationZhang, X., Wang, J., Fang, S., Tan, Y. L., Yan, H., Gu, W., & Yang, Z. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s87534 · Cited by 7
Metadata
- Authors
- Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., LaPosa, R. R., Baehner, F. L., Sagebiel, R. W., Cleaver, J. E., Haqq, C., Debs, R. J., Blackburn, E. H., & Kashani-Sabet, M.
- Affiliations
- University of California, San Francisco (US)
- California Pacific Medical Center (US)
- *Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, Comprehensive Cancer Center, and Department of Dermatology, University of California, San Francisco, CA 94115;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-07-25
- Volume
- 103
- Issue
- 30
- Pages
- 11306-11311
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1544082
- OpenAlex
- W1969066171
- Cited by
- 129
- References
- 35
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 16 · 2015: 9 · 2014: 11 · 2013: 7 · 2012: 10
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- National Cancer Institute (R01CA114337, R01CA096666, CA96840, CA96666, R01CA096840, CA114337)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03AR049378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- telomerase, melanoma, metastasis, tumor invasion, telomerase RNA, ribozyme knockdown, telomere length, tyrosinase, melanogenesis, glycolysis, glucose metabolism, lactic acid production, tumor cell morphology, downstream signaling pathways
- MeSH terms
- Animals, Cell Differentiation, Glucose, Lactates, Melanins, Melanoma, Melanoma, Experimental, Mice, Inbred C57BL, Neoplasm Invasiveness, Neoplasm Metastasis, Monophenol Monooxygenase, Gene Expression Regulation, Neoplastic, Telomerase, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.